<![CDATA[Nerviano Medical Sciences S.r.l. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=31004>Thu, 12 Mar 2026 03:55:40 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Nerviano Medical Sciences S.r.l. Announces Collaboration and Option to License Agreement with Merck]]>https://www.newswire.co.kr/newsRead.php?no=951850Thu, 22 Sep 2022 14:35:00 +0900<![CDATA[네르비아노 메디컬 사이언스-머크, 협력 및 라이선스 계약 발표]]>https://www.newswire.co.kr/newsRead.php?no=951851Thu, 22 Sep 2022 14:35:00 +0900<![CDATA[Nerviano Medical Sciences Announces Collaboration and License Agreement with Merck to Discover Small Molecule Inhibitors of Certain Anticancer Targets]]>https://www.newswire.co.kr/newsRead.php?no=870401Wed, 06 Jun 2018 12:40:00 +0900<![CDATA[네르비아노 메디컬 사이언스, 특정 암을 표적으로 하는 소분자 억제제 개발 위해 머크와 협력 및 라이선스 계약 체결]]>https://www.newswire.co.kr/newsRead.php?no=870403Wed, 06 Jun 2018 12:40:00 +0900